GlassScriptPhysician profile
Martin Aviles
NPI 1417952102
$8,250.60
in general payments reported to CMS, 2019-2025
26 companies · $278 in 2025
The $278 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $140 · 2021: $342 · 2022: $5,665 · 2023: $657 · 2024: $704 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,639.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,353.94 | 2019-2023 | Da Vinci Surgical System |
| Abbvie INC. | $503.51 | 2019-2023 | Orilissa, Lo Loestrin Fe, Liletta |
| Reapplix INC. | $455.88 | 2024 | 3c Patch Kit - Box |
| Kerecis Limited | $420.22 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Lupin INC. | $216.22 | 2019-2021 | |
| Gynesonics, INC. | $210.63 | 2022 | |
| Astellas Pharma US INC | $206.55 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $157.66 | 2021 | |
| Hologic Sales and Service, LLC | $94.72 | 2019-2025 | Novasure |
| Sage Therapeutics, LLC | $92.11 | 2021-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $81.64 | 2024-2025 | Myfembree |
| Organon LLC | $77.43 | 2021-2024 | Nexplanon |
| Acera Surgical, INC. | $68.31 | 2024 | Restrata Wound Matrix |
| Boston Scientific Corporation | $43.65 | 2020 | |
| Merck Sharp & Dohme LLC | $32.44 | 2020-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $31.91 | 2024 | 3m Cavilon, Prevena, V.A.C. Veraflo |
| Pfizer INC. | $30.09 | 2021-2024 | |
| Tei Medical INC. | $29.61 | 2019 | |
| Dexcom, INC. | $25.58 | 2024 | Dexcom G6 Transmitter |
| Convatec INC. | $20.67 | 2025 | |
| Myovant Sciences INC. | $18.96 | 2021 | |
| Organogenesis INC. | $17.97 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.31 | 2022 | |
| Novo Nordisk INC | $15.90 | 2020 | |
| Daiichi Sankyo INC. | $15.27 | 2021 | |
| Avanos Medical | $13.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Aviles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.